IRIDEX Corporation (Nasdaq: IRIX) announced today its Speakers' Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 – 21 at McCormick Place in Chicago. The Forum consists of a comprehensive 3-day schedule of activities at the IRIDEX booth featuring 13 MicroPulse presentations by 14 leading physicians, 8 of which are new to the IRIDEX podium.
The forum offers physicians from around the world an opportunity to share with their colleagues varying aspects of IRIDEX' propriety MicroPulse technology, such as clinical studies, protocols, practice integration, and financial implications. This educational program is intended to facilitate physician discussion in a relaxed peer-to-peer environment, and to offer opportunities to meet and engage with colleagues currently practicing, just getting started with, or interested in learning more about MicroPulse laser therapy.
Will Moore, IRIDEX President and CEO, commented, "Physicians are challenged with a rising number of patients suffering from glaucoma and retinal diseases, and we are pleased to create this opportunity for physicians to discuss the benefits and role of MicroPulse laser therapy to safely manage these diseases with sustainable, clinically effective results."
Select presentations from this year's program include the following:
- Why I Made the Jump to Fovea-Friendly MicroPulse Laser Therapy for the Macula, presented by Dr. Jeanne Rosenthal, Surgeon Director and Senior Attending Surgeon at the New York Eye and Ear Infirmary of Mount Sinai; and Dr. Julia Shulman, Director of Clinical Research and Associate Residency Program Director at Jamaica Hospital Medical Center in Queens and Clinical Instructor of Ophthalmology in the Pediatric Retina Division at New York Eye and Ear Infirmary of Mount Sinai. Sunday, October 19 at 11:30 AM
- Rethinking Our Regimen for Retinal Disease Management, presented by Ahad Mahootchi, MD, Medical Director of The Eye Clinic of Florida. Saturday, October 18 at 1:00 PM
- Laser Treatment Alternatives in Glaucoma, presented by Iqbal (Ike) Ahmed, MD, FRCSC, Assistant Professor and Research Fellowship Director, Department of Ophthalmology, University of Toronto. Sunday, October 19 at 2:30 PM
Using advanced AI screening tools to improve early detection of myopic maculopathy